濮阳东方很便宜濮阳东方医院看早泄价格不高,濮阳东方医院男科治疗阳痿技术非常哇塞,濮阳东方看妇科病收费透明,濮阳东方男科医院看病不贵,濮阳东方医院治早泄技术很哇塞,濮阳东方医院看男科收费标准,濮阳东方看男科病评价高

BEIJING, Sept. 30 (Xinhuanet) -- Tobacco companies concealed the knowledge of radioactive substance in cigarettes from public for over four decades, a new study revealed.The revelation was made by a research team from the University of California, Los Angeles, published on Thursday in the online edition of the U.S. medical journal Nicotine and Tobacco Research.The researchers analyzed 27 timeworn documents and discovered that tobacco companies had knew the existence of polonium-210, a hazardous radioactive substance, in the tobacco since 1959.The companies studied polonium-210 throughout the 1960s, and concealed their findings about the carcinogenic potential of the radioactive substance.Hrayr Karagueuzian, the study's lead author, said the tobacco companies' deception surprised him.According to the revelation, the companies had knew the "cancerous growths" in the lungs of smokers, and even calculated how much radiation a regular smoker would inhale over 20 years.Karagueuzian and his team conducted again the study recorded in the tobacco documents and found that the radiation in cigarettes would cause up to 138 deaths for every 1,000 smokers over a period of 25 years.However, tobacco manufacturer denied that they had concealed the facts from the public.David Sutton, spokesman of Philip Morris, the largest U.S. tobacco company, said the polonium-210 was a "naturally occurring element in the air" and had been widely discussed by the public health community for years.

WASHINGTON, Oct. 9 (Xinhua) -- U.S. researchers have found a way to block, in an animal model, the damaging inflammation that contributes to many disease conditions. In their report receiving early online publication Sunday in Nature Biotechnology, researchers describe using small interfering RNA technology to silence the biochemical signals that attract a particular group of inflammatory cells to areas of tissue damage."The white blood cells known as monocytes play a critical role in the early stages of the immune response," says Matthias Nahrendorf, of the Massachusetts General Hospital (MGH) Center for Systems Biology, the paper's senior author. "We now know there are two subsets of monocytes -- an inflammatory subset that defends against pathogens and a reparative subset that supports healing. But if the inflammatory response is excessive, it can block the healing process and exacerbate conditions such as heart disease and cancer."Cells damaged by injury or disease release a cocktail of chemicals called cytokines that attract immune cells to the site of the damage. Inflammatory monocytes are guided to sites of tissue injury by a receptor protein called CCR2, and the MGH-led team devised a strategy targeting that molecule to block the inflammatory process but not the action of the reparative monocytes.Small interfering RNA (siRNA) technology prevents production of specific proteins by binding to associated messenger RNA molecules and preventing their translation. However, the technique requires extreme precision in developing the right siRNA molecule and delivering it to the correct cellular location.To make sure that their siRNA preparation targeted the right monocytes, researchers first confirmed that its use reduced levels of CCR2 in monocytes and increased levels of the fragments produced when siRNA binds to its target. They then showed that monocytes from mice treated with the siRNA preparation were unable to migrate towards CCR2's usual molecular target. Experiments in animal models of several important diseases showed that the siRNA preparation reduced the amount of cardiac muscle damaged by a heart attack, reduced the size and the number of inflammatory cells in atherosclerotic plaques and in lymphomas, and improved the survival of transplanted pancreatic islets."These inflammatory monocytes are involved in almost every major disease," Nahrendorf explains. "Anti-inflammatory drugs currently on the market hit every inflammatory cell in the body, which can produce unwanted side effects. This new siRNA treatment doesn't affect inflammatory cells that don't rely on the CCR2 receptor. That makes a big difference."

BEIJING, Oct. 18 (Xinhuanet) -- NASA recently unveiled its new rocket design, named Space Launch System (SLS), according to media reports.The rocket will make its first unmanned flight in 2017, and the flight with astronauts aboard won't happen until 2021, according to NASA's plan.The new rocket was 320 feet in length (the space shuttle was 184 feet on the launch pad), 5.5 million pounds in weight, and with the capacity of holding four astronauts at the top speed of 25,000 miles per hour, Washington Post reported Tuesday.Compared with space shuttle and other predecessors, the new rocket will aim for much farther destinations into the space with its most powerful engine ever built, according to the plan."We're investing in technologies to live and work in space, and it sets the stage for visiting asteroids and Mars," the NASA administrator Charles Bolden briefed the media at a news conference in Washington.NASA expected to devote 3 billion U.S. dollars a year to the effort, or a total of about 18 billion U.S. dollars over the next six years, said William Gerstenmaier, the agency’s associate administrator for human exploration.The current financial condition of U.S. may slow down the pace of progress, which will be much slower than NASA's Apollo heyday in the 1960s.

BEIJING, Nov. 19 (Xinhua) -- China on Saturday again called for appropriately addressing the alleged plot to assassinate the Saudi Arabian Ambassador to the United States.Foreign Ministry Spokesman Liu Weimin made the remarks in a written statement in Beijing.The UN General Assembly on Friday adopted a resolution titled "Terrorist Attacks on Internationally Protected Persons," expressing deep concern over the assassination plot and calling on Iran "to comply with all of its obligations under international law."Liu said China abstained from the vote on the resolution, because the case is highly complicated and sensitive at present and relevant parties still have different views on the issue.He said any conclusion or action must be based on comprehensive, impartial, objective and transparent investigation and substantial evidence."Before facts are checked out, parties should adopt a prudent attitude, refrain from jumping to conclusions, and avoid actions that may complicate and worsen the situation," he said.He said China hopes those countries concerned will continue to appropriately address the issue through dialogue and make joint efforts to maintain peace and stability in the Middle East and the Gulf Region.Liu also reaffirmed that China opposes all forms of terrorism, and always stands for compliance with international law and the basic norms governing international relations in handling state-to-state relations as well as the effective protection of the safety of diplomatic personnel.Chinese Permanent Representative to the United Nations Li Baodong previously addressed the UN General Assembly on Friday in order to explain China's position on the issue after he abstained from voting on the draft resolution.

WASHINGTON, Dec. 5 (Xinhua) -- A recent study found that low vitamin D levels are significantly more prevalent in obese children and are associated with risk factors for type 2 diabetes. This study was accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism.High rates of vitamin D deficiency have been found in obese populations and past studies have linked low vitamin D levels to cardiovascular disease and type 2 diabetes. But the mechanisms by which obesity and its comorbidities are related to vitamin D deficiency are not fully known.This new study examined associations between vitamin D levels and dietary habits in obese children, and tested whether there were correlations between vitamin D levels and markers of abnormal glucose metabolism and blood pressure.In this study, researchers measured vitamin D levels, blood sugar levels, serum insulin, body mass index (BMI) and blood pressure in 411 obese subjects and 87 control non-overweight subjects. Study participants were also asked to provide dietary information including daily intake of soda, juice and milk, average daily fruit and vegetable intake, and whether or not they routinely skipped breakfast. BMI is a measurement of body fat calculated from weight and height."Our study found that obese children with lower vitamin D levels had higher degrees of insulin resistance," said Micah Olson, of The University of Texas Southwestern Medical Center in Dallas and lead author of the study. "Although our study cannot prove causation, it does suggest that low vitamin D levels may play a role in the development of type 2 diabetes.""Poor dietary habits such as skipping breakfast and increased soda and juice intake were associated with the lower vitamin D levels seen in obese children," said Olson. "Future studies are needed to determine the clinical significance of lower vitamin D levels in obese children ... and whether treatment with vitamin D can improve primary clinical endpoints such as insulin resistance. "